Advanced Point-Of-Care Liver Health Assessment

Any patient, any provider, any setting

Hepatoscope is a breakthrough non-invasive point-of-care solution for early assessment of chronic liver disease.

Easy to use, ultra-portable, and accessible to any healthcare professional, it facilitates mass triage of patients at risk of developing liver steatosis and fibrosis.

40% of patients living with Type 2 Diabetes and obesity have advanced liver fibrosis*

Do you know your patients?

How can you assess your patients?

Hepatoscope measures liver stiffness (LSM) and three steatosis-related parameters. Measurements are performed under image guidance to ensure the confidence needed for proper patient care.

Ready to integrate liver assessment in your clinical practice?

Hepatoscope is designed with ease of use in mind, allowing any healthcare professional to perform a liver exam in less than 4 minutes.

*High Prevalence of NASH and Advanced Fibrosis in Type 2 Diabetes: A Prospective Study of 330 Outpatients Undergoing Liver Biopsies for Elevated ALT, Using a Low Threshold, Castera et al. 2023

Financial Flexibility

E-Scopics proposes flexible options to acquire Hepatoscope, either via Software Suscription (pay-as-you-go) or Ownership (capital purchase), to adapt to your practice and requirements.

Contact us to understand how we can support you in developing an efficient management plan for your patients at risk of liver disease.

Clinically validated,trusted by healthcare teams globally

Validated in Hepatology, GI and Endocrinology practices in line with the latest clinical practice guidelines
Demonstrated repeatability and reproducibility of measurements
BMI-independent measurements

Hepatoscope helps clinicians manage metabolic patients confidently

“I am extremely happy with the Hepatoscope, and very impressed with its performance. It is user friendly, its performance is really precise and the results are impressive.”

Suraia Boaventura Barclay, MD, AGAF
Gastroenterologist & Endoscopist

“Its affordability, ease of implementation, and streamlined operation are the same features that position it to meet the many medical society and public health guidelines advising wider, more intentional screening of populations at risk for MASLD/MASH.”

Julio Gutierrez, MD
Transplant Hepatology, Gastroenterology

“I love Hepatoscope because it’s a simple device that’s easy to use.

Its quick, its efficient, and it gives me an accurate staging of the patient’s liver disease”

Edward Mena, MD, FAASLD, MBA Hepatology

TESTIMONIALS

We bring advanced liver health assessment to everyone

Hepatoscope is a Class IIa medical device according to Rule 10 of Annex VIII of Regulation (EU) 2017/745 (CE 2460) and is manufactured by E-Scopics.

Hepatoscope is intended to provide: general purpose pulse echo ultrasound imaging, soft tissue elasticity imaging of the human body and provides measurements of shear wave speed and tissue stiffness, ultrasound tissue brightness parameters such as ultrasound beam attenuation and backscattering coefficient, and estimates of speed of sound, in internal structures of the body. This non-invasive device is intended to aid healthcare professionals in the clinical management, diagnosis, and monitoring of patients with confirmed or suspected chronic liver disease, as part of a comprehensive liver assessment.

Hepatoscope used as an aid to the diagnosis, monitoring and clinical management of adult and pediatric patients with liver disease.

Examinations with Hepatoscope shall be performed by a healthcare professional who has been specifically trained by E-Scopics or its authorized representatives. Operators are expressly recommended to carefully read the instructions provided in the User Manual and on the product labeling.